Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.3891
+0.0145 (3.87%)
At close: Sep 22, 2026, 4:00 PM EDT
0.3890
-0.0001 (-0.03%)
After-hours: Sep 22, 2026, 7:30 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $35.75 million as of September 22, 2026. Its market cap has decreased by -58.84% in one year.
Market Cap
35.75M
Enterprise Value
-7.00M
1-Year Change
-58.84%
Ranking
Category
Stock Price
$0.39
ChartMarket Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has decreased from $51.03M to $35.75M, a decrease of -29.94%. That is a compound annual growth rate of -6.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 35.75M | -73.53% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celularity | 37.92M |
| CervoMed | 36.74M |
| BriaCell Therapeutics | 36.70M |
| aTyr Pharma | 35.61M |
| Filana Therapeutics | 35.07M |
| Quoin Pharmaceuticals | 33.92M |
| Aligos Therapeutics | 32.72M |
| NanoViricides | 32.35M |